Layer II/III of the prefrontal cortex: Inhibition by the serotonin 5-HT1A receptor in development and stress.
The modulation of the prefrontal cortex by the neurotransmitter serotonin (5-HT) is thought to play a key role in determining adult anxiety levels. Layer II/III of the prefrontal cortex, which mediates communication across cortical regions, displays a high level of 5-HT(1A) receptor binding in normal individuals and a significantly lower level in patients with mood and anxiety disorders. Here, we examine how serotonin modulates pyramidal neurons in layer II/III of the rat prefrontal cortex throughout postnatal development and in adulthood. Using whole cell recordings in brain slices of the rat medial prefrontal cortex, we observed that serotonin directly inhibits layer II/III pyramidal neurons through 5-HT(1A) receptors across postnatal development (postnatal days 6-96). In adulthood, a sex difference in these currents emerges, consistent with human imaging studies of 5-HT(1A) receptor binding. We examined the effects of early life stress on the 5-HT(1A) receptor currents in layer II/III. Surprisingly, animals subjected to early life stress displayed significantly larger 5-HT(1A)-mediated outward currents throughout the third and fourth postnatal weeks after elevated 5-HT(1A) expression during the second postnatal week. Subsequent exposure to social isolation in adulthood resulted in the almost-complete elimination of 5-HT(1A) currents in layer II/III neurons suggesting an interaction between early life events and adult experiences. These data represent the first examination of functional 5-HT(1A) receptors in layer II/III of the prefrontal cortex during normal development as well as after stress.
Goodfellow
Nathalie M
NM
Department of Physiology, University of Toronto, Ontario, Canada.
Benekareddy
Madhurima
M
Vaidya
Vidita A
VA
Lambe
Evelyn K
EK
D000375:Aging; D000818:Animals; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008426:Maternal Deprivation; D008564:Membrane Potentials; D018408:Patch-Clamp Techniques; D017397:Prefrontal Cortex / Q000254:growth & development* / Q000503:physiopathology*; D017966:Pyramidal Cells / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D044282:Receptor, Serotonin, 5-HT1A / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D012727:Sex Characteristics; D012934:Social Isolation; D013315:Stress, Psychological / Q000503:physiopathology*
D012333:RNA, Messenger; D044282:Receptor, Serotonin, 5-HT1A; D012701:Serotonin
Neuroscience. 2006 Jun 19;140(1):355-65
16530973
J Comp Neurol. 2005 Nov 14;492(2):145-77
16196030
J Neurochem. 1996 Jun;66(6):2361-72
8632158
Am J Psychiatry. 2007 Oct;164(10):1476-88
17898336
Neuroscience. 2006 Aug 25;141(2):781-794
16824687
Acta Paediatr Suppl. 1997 Jul;422:27-33
9298788
J Neuroendocrinol. 1995 Aug;7(8):653-7
8704740
Am J Psychiatry. 2001 Aug;158(8):1326-8
11481173
Neuroscience. 1999;94(1):251-9
10613515
Acta Neurobiol Exp (Wars). 2007;67(4):471-9
18320724
Birth Defects Res B Dev Reprod Toxicol. 2006 Oct;77(5):471-84
17066419
Brain Res. 2000 Feb 7;855(1):76-82
10650132
Brain Res Dev Brain Res. 1997 Feb 20;98(2):185-90
9051259
Brain Res Brain Res Protoc. 1997 Oct;1(4):364-70
9384817
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15049-54
9844013
J Neurosci. 2003 Apr 15;23(8):3373-84
12716945
Neuroscience. 2001;105(1):7-17
11483296
J Neurophysiol. 2004 Mar;91(3):1171-82
14602839
Neurosci Lett. 1991 Jun 24;127(2):173-6
1831889
Brain Res. 1995 Aug 7;688(1-2):121-33
8542298
J Neurosci. 2004 May 19;24(20):4807-17
15152041
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14476-81
9826725
Biol Psychiatry. 1999 Nov 15;46(10):1375-87
10578452
Biol Psychiatry. 1999 Dec 1;46(11):1536-41
10599481
Biol Psychiatry. 2007 May 1;61(9):1081-9
16979141
Brain Struct Funct. 2008 Feb;212(5):403-16
18200448
Brain Res. 1995 Apr 3;676(1):157-68
7796165
Neurosci Biobehav Rev. 2009 Jun;33(6):773-83
19111570
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10734-9
9724773
Int J Dev Neurosci. 1998 Jun-Jul;16(3-4):149-64
9785112
Neuroscience. 1980;5(2):207-27
6990293
J Neural Transm (Vienna). 2003 Dec;110(12):1445-53
14666415
Early Hum Dev. 1991 Jul;26(1):61-7
1914989
J Neurosci. 2003 Jun 15;23(12):5329-36
12832558
Brain Res Mol Brain Res. 1998 Sep 18;60(1):123-6
9748536
Brain Res Mol Brain Res. 1996 Jun;38(2):233-42
8793111
J Neurosci. 2004 Jan 21;24(3):589-91
14736842
Nat Rev Neurosci. 2004 Jul;5(7):545-52
15208696
Neuropharmacology. 1994 Mar-Apr;33(3-4):423-31
7984280
Neuropsychopharmacology. 2007 Jul;32(7):1504-19
17164818
Brain Res. 1997 Jan 16;745(1-2):96-108
9037397
Mol Pharmacol. 1994 Dec;46(6):1111-9
7808431
Brain Res. 1994 Jun 13;648(1):157-61
7922518
J Comp Neurol. 2002 Aug 26;450(3):241-55
12209853
Brain Res Dev Brain Res. 2002 Jan 31;133(1):1-11
11850058
Neuropsychopharmacology. 2008 Jan;33(1):134-40
17851538
J Neurosci. 2008 Jun 11;28(24):6250-7
18550767
J Biol Chem. 2001 Apr 27;276(17):14299-307
11278286
Brain Res. 2003 Oct 31;989(1):42-51
14519510
Mol Psychiatry. 2004 Apr;9(4):386-92
15042104
J Pharmacol Exp Ther. 1998 Mar;284(3):1227-33
9495887
Biol Psychiatry. 2001 Jun 15;49(12):1023-39
11430844
Neuroreport. 1993 Oct 25;5(1):61-4
8280861
Brain Res Dev Brain Res. 2004 Mar 22;149(1):39-44
15013627
Neurosci Biobehav Rev. 2008 Sep;32(7):1293-314
18439676
Nature. 2002 Mar 28;416(6879):396-400
11919622
J Neurosci. 2003 Nov 26;23(34):10841-51
14645477
Brain Res Bull. 1982 Apr;8(4):389-430
6178481
Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):245-72
11750782
Cereb Cortex. 2005 Jun;15(6):802-8
15371297
Neuroscience. 2007 Jul 29;147(4):1022-33
17587501
Brain Res Mol Brain Res. 2000 Oct 20;82(1-2):65-73
11042358
Brain Res. 2002 Nov 8;954(2):173-82
12414100
J Comp Neurol. 2000 Feb 7;417(2):181-94
10660896
Neuroimage. 2008 Feb 1;39(3):1408-19
18036835
J Neurosci Res. 1996 Dec 15;46(6):697-708
8978504
Brain Res Dev Brain Res. 1999 May 14;114(2):245-52
10320763